{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:35:08Z","timestamp":1788903308400,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017317","name":"Catholic Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.cct.2021.106631","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T11:51:20Z","timestamp":1637754680000},"page":"106631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The BROADEN study: The design of an observational study to assess the absolute burden of HPV-related head and neck cancers"],"prefix":"10.1016","volume":"115","author":[{"given":"Edith","family":"Morais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"G\u00f3mez-Ulloa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Fenoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel \u00c0ngel","family":"Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham","family":"Mehanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha\u00eftham","family":"Mirghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Alemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2021.106631_bb0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cct.2021.106631_bb0010","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/annonc\/mdz084","article-title":"Head and neck cancer prevention: from primary prevention to impact of clinicians on reducing burden","volume":"30","author":"Hashim","year":"2019","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cct.2021.106631_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv403","article-title":"HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients","volume":"108","author":"Castellsagu\u00e9","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cct.2021.106631_bb0020","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","article-title":"Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis","volume":"8","author":"de Martel","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.cct.2021.106631_bb0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.cct.2021.106631_bb0030","first-page":"E1863","article-title":"Geographic variation in human papillomavirus-related oropharyngeal cancer: data from 4 multinational randomized trials","volume":"38","author":"Mehanna","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.cct.2021.106631_bb0035","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cct.2021.106631_bb0040","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1093\/annonc\/mdx304","article-title":"Human papillomavirus-related oropharyngeal cancer","volume":"28","author":"Taberna","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cct.2021.106631_bb0045","series-title":"31st International Papillomavirus Conference & Clinical Workshop. Cape Town, South Africa","article-title":"Overall burden of cancers associated with the 9-valent human papillomavirus vaccine types in women and men in Europe","author":"Hartwig","year":"2017"},{"key":"10.1016\/j.cct.2021.106631_bb0050","article-title":"Design of a Phase III efficacy, immunogenicity and safety study of 9-valent human papillomavirus vaccine in prevention of oral persistent infection in men","author":"Giuliano","year":"2021","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.cct.2021.106631_bb0055","series-title":"The Prevalence and Risk Factors for Oral HPV Infection in a Healthy Multicountry Population \u2013 The PROGRESS Study Design","author":"Morais","year":"2021"},{"key":"10.1016\/j.cct.2021.106631_bb0060","author":"ECIS"},{"key":"10.1016\/j.cct.2021.106631_bb0065","series-title":"Report of Head and Neck Cancer Registry of Japan Clinical Statistics of Registered Patients","author":"Cancer JSfHaN","year":"2017"},{"key":"10.1016\/j.cct.2021.106631_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pvr.2016.07.002","article-title":"Low prevalence of HPV-driven head and neck squamous cell carcinoma in north-East Italy","volume":"2","author":"Baboci","year":"2016","journal-title":"Papillomavirus Res."},{"key":"10.1016\/j.cct.2021.106631_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.oraloncology.2017.01.012","article-title":"Oropharyngeal cancer prognosis by tumour HPV status in France: the multicentric Papillophar study","volume":"67","author":"Lacau St Guily","year":"2017","journal-title":"Oral Oncol."},{"key":"10.1016\/j.cct.2021.106631_bb0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/cas.12369","article-title":"Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population","volume":"105","author":"Maruyama","year":"2014","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cct.2021.106631_bb0085","series-title":"Impacto de la incidencia del virus del papiloma humano (VPH) en c\u00e1ncer de orofaringe (2015\u20132017). II Congreso multidisciplinar de C\u00e1ncer de cabeza y cuello para adjuntos j\u00f3venes y residentes","author":"Molina","year":"2018"},{"key":"10.1016\/j.cct.2021.106631_bb0090","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fonc.2017.00129","article-title":"Prognostic impact of AJCC\/UICC 8th edition new staging rules in oropharyngeal squamous cell carcinoma","volume":"7","author":"Wurdemann","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cct.2021.106631_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cjp2.111","article-title":"Current status of clinical testing for human papillomavirus in oropharyngeal squamous cell carcinoma","volume":"4","author":"Kim","year":"2018","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.cct.2021.106631_bb0100","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ijc.1174","article-title":"Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri","volume":"92","author":"Klaes","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cct.2021.106631_bb0105","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0002-9440(10)63871-0","article-title":"Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus","volume":"162","author":"Klussmann","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cct.2021.106631_bb0110","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/ijc.30516","article-title":"Diagnostic accuracy of p16(INK4a) immunohistochemistry in oropharyngeal squamous cell carcinomas: a systematic review and meta-analysis","volume":"140","author":"Prigge","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cct.2021.106631_bb0115","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/ijc.22980","article-title":"A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen","volume":"121","author":"Smeets","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cct.2021.106631_bb0120","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/cncr.25033","article-title":"Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience","volume":"116","author":"Singhi","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.cct.2021.106631_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2012.07.002","article-title":"Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas","volume":"49","author":"Lingen","year":"2013","journal-title":"Oral Oncol."},{"key":"10.1016\/j.cct.2021.106631_bb0130","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.18.00684","article-title":"Human papillomavirus testing in head and neck carcinomas: ASCO clinical practice guideline endorsement of the College of American Pathologists Guideline","volume":"36","author":"Fakhry","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cct.2021.106631_bb0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","article-title":"Human papillomavirus testing in head and neck carcinomas: guideline from the College of American Pathologists","volume":"142","author":"Lewis","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.cct.2021.106631_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2021.106631_bb0145","first-page":"122","article-title":"Head and neck cancers-major changes in the American joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Lydiatt","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cct.2021.106631_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1200\/EDBK_199697","article-title":"Major changes in head and neck staging for 2018","volume":"38","author":"Lydiatt","year":"2018","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"10.1016\/j.cct.2021.106631_bb0155","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.tranon.2019.05.009","article-title":"HPV and oropharyngeal Cancer in the eighth edition of the TNM classification: pitfalls in practice","volume":"12","author":"Hoffmann","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.cct.2021.106631_bb0160","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","article-title":"Development and validation of a staging system for HPV-related oropharyngeal cancer by the international collaboration on oropharyngeal cancer network for staging (ICON-S): a multicentre cohort study","volume":"17","author":"O\u2019Sullivan","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cct.2021.106631_bb0165","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1186\/s12885-019-5894-8","article-title":"Validation of the 8(th) edition UICC\/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy","volume":"19","author":"van Gysen","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cct.2021.106631_bb0170","series-title":"Pathology and Genetics of Head and Neck Tumours","author":"World Health Organization Classification of Tumours","year":"2005"},{"key":"10.1016\/j.cct.2021.106631_bb0175","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cct.2021.106631_bb0180","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/ijc.30697","article-title":"Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma","volume":"140","author":"Holzinger","year":"2017","journal-title":"Int. J. Cancer"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714421003670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714421003670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:56:30Z","timestamp":1761555390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714421003670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":36,"alternative-id":["S1551714421003670"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2021.106631","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The BROADEN study: The design of an observational study to assess the absolute burden of HPV-related head and neck cancers","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2021.106631","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc., Kenilworth, NJ USA and The Author(s). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106631"}}